Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
Public ClinicalTrials.gov record NCT01892813. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tailored Tobacco Intervention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The project is designed to examine the effectiveness of strategies to increase access to treatment for tobacco use and dependence among rural Veteran smokers. In addition, it will examine whether tailored treatment that is designed to address common comorbid conditions that are related to cigarette smoking enhances success with quitting relative to enhanced standard of care. The investigators hypothesize that participants assigned to the tailored tobacco cessation intervention will report greater cessation rates at six months. The investigators also anticipate more favorable outcomes on measures of depressive symptoms, alcohol use, and body weight.
Study identification
- NCT ID
- NCT01892813
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 411 participants
Conditions and interventions
Conditions
Interventions
- Nicotine replacement therapy - Transdermal nicotine patch Drug
- Nicotine replacement therapy - Nicotine gum Drug
- Nicotine replacement therapy - Nicotine lozenge Drug
- Bupropion Drug
- Varenicline Drug
- Combination pharmacotherapy - Transdermal nicotine patch + nicotine gum Drug
- Combination pharmacotherapy - Transdermal nicotine patch + nicotine lozenge Drug
- Combination pharmacotherapy - Transdermal nicotine patch + bupropion Drug
- Tobacco quitline referral Behavioral
- Tailored behavioral intervention Behavioral
- Alcohol use risk reduction Behavioral
- Behavioral activation for depressive symptoms Behavioral
- Behavioral management of postcessation weight gain Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2013
- Primary completion
- Dec 31, 2017
- Completion
- Dec 31, 2017
- Last update posted
- Jul 10, 2017
2013 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Iowa City VA Healthcare System | Iowa City | Iowa | 52246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01892813, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2017 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01892813 live on ClinicalTrials.gov.